If you had invested $1,000 in Bristol-Myers Squibb Company (BMY)

10 years ago (Mon, Nov 21, 2016), $1,000 in BMY grew to $1,480 by Fri, Nov 20, 2026 with dividends reinvested ($1,036 on price alone). The same $1,000 in SPY grew to $3,672. Along the way BMY fell as much as -47.7% from a high. Past results do not tell you what happens next.

InvestedBMY, dividends reinvestedPer yearWorst fallSPYSPY per year
1 year ago$1,337+33.7%-15.9%$1,069+6.9%
3 years ago$1,385+11.5%-29.9%$1,575+16.3%
5 years ago$1,268+4.9%-47.7%$1,578+9.6%
10 years ago$1,480+4.0%-47.7%$3,672+13.9%

Today: model fair value $97.88 against a $58.80 price (gap +66.5%).

Split-adjusted closes; 40 cash dividends reinvested on their ex-dividend dates, before taxes and costs. SPY on its total-return price. Data as of Fri, Nov 20, 2026.

Full BMY valuation · Other companies